Concomitant use of tamoxifen and endoxifen in postmenopausal early breast cancer: prediction of plasma levels by physiologically-based pharmacokinetic modeling
Crossref DOI link: https://doi.org/10.1186/2193-1801-3-285
Published Online: 2014-06-05
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Dickschen, Kristin
Eissing, Thomas
Mürdter, Thomas
Schwab, Matthias
Willmann, Stefan
Hempel, Georg
Article History
Received: 8 May 2014
Accepted: 28 May 2014
First Online: 5 June 2014